RIBOSPHERE Trademark

Trademark Overview


On Thursday, February 4, 2021, a trademark application was filed for RIBOSPHERE with the United States Patent and Trademark Office. The USPTO has given the RIBOSPHERE trademark a serial number of 90510222. The federal status of this trademark filing is REGISTERED as of Tuesday, March 15, 2022. This trademark is owned by BioNTech SE. The RIBOSPHERE trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for medical and veterinary purposes for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleic acids for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that p...
ribosphere

General Information


Serial Number90510222
Word MarkRIBOSPHERE
Filing DateThursday, February 4, 2021
Status700 - REGISTERED
Status DateTuesday, March 15, 2022
Registration Number6670067
Registration DateTuesday, March 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements


Goods and ServicesChemical preparations for medical and veterinary purposes for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleic acids for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of active ingredients for pharmaceuticals for use in the treatment of cancer, autoimmune disorders, genetic defects, and metabolic disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioNTech SE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMainz 55131
DE

Party NameBioNTech SE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMainz 55131
DE

Party NameBioNTech SE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMainz 55131
DE

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 6, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, February 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 15, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 7, 2021NON-FINAL ACTION E-MAILED
Tuesday, September 7, 2021NON-FINAL ACTION WRITTEN
Friday, August 27, 2021ASSIGNED TO EXAMINER
Saturday, May 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 19, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, February 19, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, February 8, 2021NEW APPLICATION ENTERED